Epidemiology of Childhood Asthma

Global and Regional Prevalence

Asthma is one of the most common chronic diseases in children worldwide, with significant geographic variation:

  • The prevalence in Saudi children ranges from 8% to 25%, representing a significant burden on healthcare systems.
  • Global prevalence continues to rise, especially in developing countries adopting Western lifestyles.

Demographic Patterns

Sex Distribution

Differs depending on age of onset:

  • Males > Females before puberty
  • Females > Males after puberty

Age of Onset

Typically begins in childhood:

  • ~80% of cases begin before age 6
  • Peak incidence at 3-6 years of age

Etiology: A Multifactorial Disease

Childhood asthma results from a complex interplay between:

  • Inherent biological and genetic vulnerabilities
  • Environmental exposures and triggers

Primary Risk Factors

  • Family history of asthma (particularly maternal)
  • Personal history of allergic conditions
  • Atopic dermatitis in early life
  • Prenatal factors (maternal smoking, diet)

Common Triggers

  • Environmental allergens: pollen, dust mites, pet dander
  • Viral respiratory infections: especially RSV, rhinovirus
  • Physical factors: exercise, cold air, laughter
  • Irritants: tobacco smoke, air pollution, strong odors
  • Medications: NSAIDs, beta-blockers
  • Comorbidities: GERD, chronic sinusitis, obesity
  • Psychological stress

img-2.jpeg Diagram showing relationship between genetic predisposition and environmental factors in asthma development


Pathophysiology: Inflammatory Cascade

Key Mechanisms in Asthma Pathophysiology

img-3.jpeg|0x0

  • Allergen Exposure
    • Initial sensitization to allergens activates dendritic cells and T-helper lymphocytes
  • Inflammatory Response
    • Release of cytokines (IL-4, IL-5, IL-13) and recruitment of inflammatory cells (eosinophils, mast cells)
  • Airway Effects
    • Bronchoconstriction, mucus hypersecretion, airway edema, and eventual airway remodeling

This chronic inflammatory process leads to airway hyperresponsiveness and variable airflow limitation that produces the characteristic symptoms of asthma.

img-4.jpeg

Asthma is an inflammatory disease driven by T-helper type 2 cells (Th2-cell) that manifests in individuals with a genetic predisposition.

Inflammatory cells (mast cells, eosinophils, T lymphocytes, neutrophils), chemical mediators (histamine, leukotrienes, platelet-activating factor, bradykinin), and chemotactic factors (cytokines(IL-3, IL-4, IL-5, IL-13), eotaxin) mediate the underlying inflammation found in asthmatic airways.

Airway Changes in Asthma

Structural and Functional Changes

Asthma involves multiple physiological alterations in the airways:

  • Bronchial smooth muscle hypertrophy and hyperreactivity
  • Mucus gland hyperplasia leading to increased secretions
  • Epithelial damage and basement membrane thickening
  • Inflammatory cell infiltration (eosinophils, T-cells)
  • Vascular permeability causing mucosal edema

These changes result in the characteristic airflow limitation that manifests as wheezing, cough, and dyspnea during exacerbations.

img-5.jpegimg-6.jpegimg-7.jpeg

Pathophysiologic Consequences in Pediatric Asthma

Acute Effects

  • Bronchoconstriction from smooth muscle contraction
  • Increased mucus production obstructing airways
  • Mucosal edema reducing airway diameter
  • Air trapping due to expiratory airflow limitation

Chronic Effects

  • Airway remodeling with subepithelial fibrosis
  • Permanent changes in airway architecture
  • Decreased lung function over time
  • Reduced response to bronchodilators

These changes are often more reversible in children than adults, highlighting the importance of early intervention and consistent management.

img-8.jpeg


Clinical Presentation of Childhood Asthma

Typical Features

These symptoms typically occur either sporadically or in response to specific triggers:

  • Persistent, dry cough that worsens at night, with exercise, or exposure to triggers
  • End-expiratory wheezing - generalized polyphonic expiratory wheeze with prolonged expiration
  • Dyspnea - shortness of breath, especially during exacerbations
  • Chest tightness - described by older children as “chest hurting”
  • Prolonged expiratory phase on auscultation
  • Hyperresonance to lung percussion during acute episodes
  • Harrison’s sulci (indentations of the chest wall) may result from early-onset disease

☐ Intermittent dry coughing and expiratory wheezing are the most common chronic symptoms of pediatric asthma.

Atypical Presentations

  • Exercise-induced asthma
  • Cough-variant asthma
  • Seasonal or episodic asthma

Common Comorbidities

  • Allergic rhinitis
  • Atopic dermatitis
  • Food allergies
  • Gastroesophageal reflux

img-15.jpeg


Patient with Respiratory Symptoms: Age-Based Approach

Children aged ≤5 years:

  • Cough
  • Wheeze
  • Difficulty breathing/shortness of breath
  • Reduced activity
  • Past/family history
  • Symptoms worsen with viral infection or at night/upon waking

Children aged 6–11 years:

  • Cough
  • Wheeze
  • Symptoms occur variably over time and intensity also varies
  • Shortness of breath/chest tightness
  • Symptoms triggered by exercise
  • Symptoms worsen with viral infection or at night/upon waking

Assessment Steps:

  1. Test for atopy
  2. Chest X-ray could rule out structural abnormalities
  3. Risk profiles
  4. Spirometry to assess lung function
  5. Bronchial provocation testing
  6. FeNO measurement

Decision:

  • Results consistent with asthma? Treat for asthma
  • History or test results not consistent with asthma? Consider alternative diagnosis